SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-045489
Filing Date
2010-05-06
Accepted
2010-05-06 16:05:54
Documents
5
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b80508e10vq.htm 10-Q 485055
2 EX-31.1 SECTION 302 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER b80508exv31w1.htm EX-31.1 8309
3 EX-31.2 SECTION 302 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER b80508exv31w2.htm EX-31.2 8578
4 EX-32.1 SECTION 906 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER b80508exv32w1.htm EX-32.1 3669
5 EX-32.2 SECTION 906 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER b80508exv32w2.htm EX-32.2 3419
  Complete submission text file 0000950123-10-045489.txt   510491
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50743 | Film No.: 10808186
SIC: 2834 Pharmaceutical Preparations